Alnylam Pharmaceuticals
ALNY
#799
Rank
HK$243.96 B
Marketcap
HK$1,823
Share price
2.47%
Change (1 day)
-50.68%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company